FDA Import Refusal AEK-6046054-7/21/1 — Serdia Pharmaceuticals (India)
The FDA refused shipment AEK-6046054-7/21/1 from Serdia Pharmaceuticals (India) (India) on Jun 27, 2019. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 27, 2019
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY99 ANTI-DIABETIC N.E.C.
- Charges
- 75